Jon
1.7K posts


Over $50M has now been spent on services by agents using x402 More than 85% of it happened on Base



🤖⛓️ ~180k agents transacting onchain on a monthly basis, mostly on @solana and @base. Still early.

The OpenGenome Hantavirus Early Signal Challenge has officially concluded. Over the past few days, participants from around the community submitted anonymized biomedical signal reports through the OpenGenome pipeline, helping stress-test decentralized early outbreak detection and on-chain research coordination. Final rankings have now been completed, and all rewards. Including $oGNOME allocations and SOL bonuses will be distributed within the next 24 hours. Final leaderboard: opengenome.bio/contest/leader… Thank you to everyone who contributed to this first public challenge. More Open Studies and disease-focused research events will follow.


Treasury Update Since launching the $oGNOME service payment system 3 days ago, the treasury has accumulated 778,000 oGNOME and 0.3157 SOL entirely from mint fees paid by users to access the biomedical analysis pipeline. opengenome.bio/treasury At 778,000 oGNOME the protocol is now at 78% of the 1,000,000 oGNOME trigger threshold. When it hits, the first automated on-chain cycle fires: • 30% of oGNOME is burned permanently • 70% of that SOL routes to the staking vault and ops every report minted on OpenGenome requires oGNOME as payment: 1,000 oGNOME for public mints and 5,000 oGNOME for wallet mints. This is how the protocol generates revenue: not from trading fees or token speculation, but from actual usage of the biomedical analysis pipeline.

OpenGenome is a biomedical signal analysis platform built on Solana We describe what we are doing as Decentralized Science, or DeSci. That word is not branding. It is a description of how this project actually works. There is no venture capital firm behind OpenGenome. There is no lead investor holding a large allocation who can exit when the price suits them. The funding, the data, and the direction of this project come from the community that participates in it. People who contribute their biomedical signal data are not users in the traditional sense. They are contributors, and their contribution is recorded permanently on-chain in a way that cannot be altered or taken from them. This is a deliberate choice. Most biomedical research today is shaped by whoever funds it. When funding comes from institutions that need a financial return, that influences what gets studied, who owns the results, and who benefits from them. DeSci is a direct response to that. When funding and knowledge come from the community, the community also holds what gets built from it. Our observational study is registered on ClinicalTrials.gov under identifier NCT07578610, and is indexed by the WHO International Clinical Trials Registry Platform (ICTRP). Study name: OGNOME-OBS-2026-001 Status: Actively recruiting Target participants: 10,000 Period: May 2026 through May 2028 ClinicalTrials.gov is operated by the U.S. National Library of Medicine. Getting listed there requires submitting a structured protocol that is publicly searchable by anyone. It is not a paid placement and it is not self-reported. To give that context: two other organizations in the same registry are Eli Lilly and Company, a 150-year-old S&P 100 pharmaceutical company with $65 billion in annual revenue (en.wikipedia.org/wiki/Eli_Lilly…), and Spectrum Pharmaceuticals, a Nasdaq-listed oncology company with $109 million in annual revenue (en.wikipedia.org/wiki/Spectrum_…). We are not the same size as these organizations. The verification standard applied to their submissions, however, is the same standard applied to ours. Eli Lilly and Spectrum Pharmaceuticals are mentioned here purely as context to illustrate what ClinicalTrials.gov registration means in practice. We are not positioning ourselves as competitors to either organization, and we have no affiliation with them. $oGNOME is the utility token of the OpenGenome protocol. It is used to access Wellness Guidance, the Herb Directory, and the Herb Marketplace. Marketplace transactions split 93% to the vendor and 7% to the protocol. Every transaction generates a compressed NFT receipt on-chain as a permanent record. Platform: opengenome.bio Blog: opengenome.bio/blog NCT07578610 registration announcement: opengenome.bio/blog/nct-confi… ClinicalTrials.gov registry page: opengenome.bio/clinicaltrials… oGNOME token utility: opengenome.bio/blog/ognome-to…





Gm guys Tomorrow is one week since i started with 260$ I will bring this to 6 figures The journey goes on 🫡


Gm legends, I moved 270$ to a phantom wallet and since yesterday i'm 404% - 969$ up Let's see how quick will i send it to 6 figures 👀🫡 #Solana


Today we’re announcing $1 billion in new funds to back the bold founders shaping the next era of finance and technology. I’ve been following the flow of assets my entire career and have never seen a more dynamic time. Financial infrastructure is being rebuilt from the ground up, new assets and markets are emerging, and an agentic economy is developing as AI agents begin to transact on behalf of humans. These areas, among others, are what will define the coming years as we deploy these new funds. We’re excited for what’s ahead, and wrote about our thesis in the post below.

$RIV is gonna be the best play of 2026. Just watch.

